HomeCompareRYOCX vs JNJ

RYOCX vs JNJ: Dividend Comparison 2026

RYOCX yields 4.71% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYOCX wins by $7.2K in total portfolio value
10 years
RYOCX
RYOCX
● Live price
4.71%
Share price
$85.64
Annual div
$4.03
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.2K
Annual income
$637.00
Full RYOCX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RYOCX vs JNJ

📍 RYOCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRYOCXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RYOCX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RYOCX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYOCX
Annual income on $10K today (after 15% tax)
$400.45/yr
After 10yr DRIP, annual income (after tax)
$541.45/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $162.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYOCX + JNJ for your $10,000?

RYOCX: 50%JNJ: 50%
100% JNJ50/50100% RYOCX
Portfolio after 10yr
$23.6K
Annual income
$732.39/yr
Blended yield
3.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RYOCX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYOCX buys
0
JNJ buys
0
No recent congressional trades found for RYOCX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRYOCXJNJ
Forward yield4.71%3.36%
Annual dividend / share$4.03$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$27.2K$20.0K
Annual income after 10y$637.00$827.78
Total dividends collected$5.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RYOCX vs JNJ ($10,000, DRIP)

YearRYOCX PortfolioRYOCX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,171$471.11$10,676$355.77+$495.00RYOCX
2$12,445$491.86$11,407$389.39+$1.0KRYOCX
3$13,828$512.09$12,198$426.53+$1.6KRYOCX
4$15,328$531.79$13,056$467.62+$2.3KRYOCX
5$16,952$550.90$13,987$513.12+$3.0KRYOCX
6$18,708$569.41$14,998$563.56+$3.7KRYOCX
7$20,605$587.28$16,098$619.52+$4.5KRYOCX
8$22,652$604.51$17,295$681.69+$5.4KRYOCX
9$24,858$621.09$18,599$750.82+$6.3KRYOCX
10$27,235$637.00$20,022$827.78+$7.2KRYOCX

RYOCX vs JNJ: Complete Analysis 2026

RYOCXStock

The investment seeks to provide investment results that correspond, before fees and expenses, to the NASDAQ-100 Index® for over-the-counter securities on a daily basis. The fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and derivative instruments. It will invest at least 80% of its net assets, plus any borrowings for investment purposes, in securities of companies in the underlying index and derivatives and other instruments whose performance is expected to correspond to that of the underlying index. The fund is non-diversified.

Full RYOCX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RYOCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYOCX vs SCHDRYOCX vs JEPIRYOCX vs ORYOCX vs KORYOCX vs MAINRYOCX vs ABBVRYOCX vs MRKRYOCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.